Loading...

TARS TARSUS PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

TRSS

TRS

TARSUS PHARMACEUTICALS INC

(TARS)

2025 8-K

Show Summary

Show Summary

Financial Statements

Financial Results

Corporate Presentation

New Lease Agreement

Financial Results

Management Change

Financial Results

Annual Meeting of Stockholders

Financial Results

Underwriting Agreement

Earnings Reports

Departure of Chief Medical ...

Publication of Corporate Pr...

Clinical Trial Results

Earnings Reports

Financial Results

Underwriting Agreement

New Product Launches

Annual Meeting of Stockholders

Virtual Investor Webcast

Financial Results

Management Changes

Financial Results

Entry into Material Definit...

External Links:

On March 12, 2025, Tarsus Pharmaceuticals entered into an Underwriting Agreement for the sale of 2,808,988 shares at $44.50 each, expecting to raise approximately $117.1 million, with the offering closing on March 14, 2025.

AI Assistant

TARSUS PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.